Mettler-Toledo International, Inc. $MTD Shares Sold by Cresset Asset Management LLC

Key Points

• Cresset Asset Management LLC reduced its holdings in Mettler-Toledo International by 20.9%, leaving them with 790 shares valued at approximately $933,000 at the end of the last quarter.
• Mettler-Toledo International's recent quarterly earnings report revealed an EPS of $10.09, exceeding estimates of $9.58, with revenue reaching approximately $983.22 million, a 3.9% year-over-year increase.
• Analysts have mixed views on Mettler-Toledo, with some upgrading and downgrading ratings, while the stock currently holds a consensus rating of "Moderate Buy" and an average target price of $1,311.11.

Cresset Asset Management LLC lowered its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 20.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 790 shares of the medical instruments supplier's stock after selling 209 shares during the period. Cresset Asset Management LLC's holdings in Mettler-Toledo International were worth $933,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Gen Wealth Partners Inc increased its stake in shares of Mettler-Toledo International by 22.8% during the first quarter. Gen Wealth Partners Inc now owns 647 shares of the medical instruments supplier's stock valued at $764,000 after buying an additional 120 shares during the period. Ethic Inc. increased its stake in shares of Mettler-Toledo International by 1.6% during the first quarter. Ethic Inc. now owns 2,440 shares of the medical instruments supplier's stock valued at $2,822,000 after buying an additional 39 shares during the period. Martin Currie Ltd. boosted its position in Mettler-Toledo International by 3.9% during the first quarter. Martin Currie Ltd. now owns 57,992 shares of the medical instruments supplier's stock valued at $68,483,000 after purchasing an additional 2,180 shares in the last quarter. Horizon Investments LLC boosted its position in Mettler-Toledo International by 4.2% during the first quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier's stock valued at $353,000 after purchasing an additional 12 shares in the last quarter. Finally, OneAscent Investment Solutions LLC bought a new stake in Mettler-Toledo International during the first quarter valued at about $468,000. Hedge funds and other institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director owned 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider directly owned 94 shares of the company's stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,889 shares of company stock worth $3,603,054. 0.77% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on MTD. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Barclays began coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective on the stock. Robert W. Baird raised their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Citigroup raised their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research report on Thursday. Finally, Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price objective for the company from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Mettler-Toledo International Price Performance

NYSE MTD traded down $31.57 during trading on Monday, hitting $1,289.88. The company's stock had a trading volume of 85,847 shares, compared to its average volume of 173,391. The company has a market cap of $26.57 billion, a PE ratio of 32.66, a P/E/G ratio of 3.97 and a beta of 1.34. The business's 50 day simple moving average is $1,227.64 and its 200-day simple moving average is $1,186.72. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.